Anna Zimmerman, M.D., Division of Neonatology within the Department of Pediatrics at the University of Minnesota

EDUCATION

University of Minnesota, Neonatal-Perinatal Fellowship     2006-Current
    420 Delaware St. SE
    Minneapolis, MN
    Expected graduation July 2009

University of Minnesota, Pediatric Residency                      2003-2006
    420 Delaware St. SE
    Minneapolis, MN

 University of North Carolina School of Medicine                1998-2003
    Chapel Hill, NC
    MD, May 2003

 University of North Carolina School of Public Health          2001-2003
    Health Leadership and Prevention Program
    Chapel Hill, NC
    MPH, May 2003

 North Carolina State University                                            1994-1998
    Raleigh, NC
    BS in Biochemistry, summa cum laude (GPA = 3.96)

HONORS & AWARDS

 North Carolina State University:

• Phi Beta Kappa, 1996
• Phi Kappa Phi, 1996
• Dean’s List all semesters
• University Scholars Program and Biochemistry Honors Program
• Gamma Sigma Delta Honor society – for outstanding academics, 1995
• Phi Eta Sigma – freshman honor society, 1995

AAP INVOLVEMENT

• Distric VI Coordinator for AAP Resident Section and Executive Committee Member, 2005 - 2006
• District VI Assistant Coordinator for Resident Section of the American Academy of Pediatrics, Executive Committee Member, 2004 – present
• University of Minnesota representative to Minnesota Chapter AAP

RESEARCH ACTIVITIES

 Pediatric Injury Prevention Counseling Study         Dec. – Jan. 1999
Preceptors: Dr. Clay Bordley, Department of Pediatrics
                  Dr. Tamera Coyne-Beasley, MD, MPH, Department of Pediatrics
Description: An injury prevention study conducted in the pediatric Emergency Department at UNC Chapel Hill Hospitals to assess the general injury prevention behaviors of families with children under age 16 and to assess issues of injury prevention counseling. 

Research Assistant                                                     May – June 1999
GlaxoWellcome Department of Virology - HIV
Primarily responsible for development of rapid detection of HIV resistance mutations using RT-PCR and ABI 7700 technology. 

Research Assistant                                                     May. 1997 – Sept. 1998
GlaxoWellcome Department of Virology-HIV
Focused on pediatric HIV disease. Carried HIV-positive cell lines in BSL-3 facility. Preformed genotypic and phenotypic resistance analyses of clinical HIV samples. DNA extraction and RT-PCR on human tissue and plasma samples. Responsible for genotypic analysis of clinical HIV samples obtained from plasma and CSF of patients treated with AZT.

PUBLICATIONS & ABSTRACTS

1.  Vavro, C.L., Zimmermann, A.M., McClernon, S. L. Kehne, S.L., Martel, L.A., Valentine, M.E., McKinney, R.E. 1999.  Virologic Response of 9 Therapy-Experienced Children Receiving 64 Weeks of Nelfinavir Salvage Therapy.  Annals of the New York Academy of Sciences, 918: 381-5, 2000 Nov.
   
2. Ross, L.L., Zimmermann, A.M., ACTG Protocol Team  AND Vavro, C.L.  Rapid Detection of the HIV Type 1 Reverse Transcriptase Codon T215Y by Reverse Transcriptase-Polymerase Chain Reaction with Fluorogenic Probes. AIDS Research and Human Retroviruses 15(14): 1287-1292, 1999 Sept. 20.
   
3. Vavro, C.L., McClernon, D.R., Zimmermann, A., Valentine, M.E.,  McKinney, R. E., St. Clair, M. H.  1997.  Correlation of Tissue HIV-1 RNA Viral Loads and Clinical History of Two Pediatric Autopsies.  5th Conference on Retroviruses and Opportunistic Infections.  Chicago, IL February 1-5, 1998. (Abstract)   
   
4. Strizki, J.M., Vavro, C.L., Shieh, J., Albright, A., Zimmermann, A., Valentine, M.E.,  McKinney, R. E.  Gonzalez-Scarano, F.  Co-Receptor use by Pediatric HIV-1 Isolates.  Keystone Symposia - HIV Pathogenesis.   Park City, UT March 13-19, 1998. (Abstract)     
   
5. Valentine, M.E., Jackson, C.R., Vavro, C.L., McClernon, D.R., A., Zimmermann, St. Clair, M.H., McKinney, R.E. .  Clinical Implications of HIV Phenotype on a Cohort of 75 Infected Children.  Society for Pediatric Research / American Pediatric Society. New Orleans, LA  May 1-5, 1998. (Abstract)
   
6. Vavro, C.L., Zimmermann, A.M., McClernon, D.R., Martel, L.A., Ross, L.L., Valentine, M.E., McKinney, R.E. Virologic Response of 12 Therapy Experienced Children Receiving 24 Weeks of Nelfinavir Triple Therapy.  International Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA   September 24-27, 1998. (Abstract)
   
7. Ross, L.L., Zimmermann, A.M., ACTG Protocol Team  AND Vavro, C.L.  A Novel Method to Determine the Percentage of Mutant HIV-1 Present in Viral Supernatants at RT Codon 215.. International Conference on Antimicrobial Angents and Chemotherapy, San Diego, CA   September 24-27, 1998. (Abstract)
   
8. Vavro, C.L., Zimmermann, A.M., ROZENBAUM^, W.  on behalf of Combivir^TM French Study Group. Virologic and Genotypic Equivalence seen in study NUCB 3027 – ZDV/3TC given in combination versus Combivir^TM. Infectious Diseases Society of America.    Denver, CO  November 12-15  ,1998. (Abstract)
   
9. Vavro, C.L., Zimmermann, A.M., McClernon, S. L. Kehne, S.L., Martel, L.A., Valentine, M.E., McKinney, R.E. Virologic Response of 9 Therapy-Experienced Children Receiving 64 Weeks of Nelfinavir Salvage Therapy.   Advances in Pediatric AIDS, Montreal, Canada  September 5-6, 1999. (Abstract)